What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Endocrinology
- Enzyme
Akira Arimura mainly investigates Endocrinology, Internal medicine, Somatostatin, Hypothalamus and Hormone.
His Endocrinology research integrates issues from Antiserum and Vasoactive intestinal peptide.
His Internal medicine study is mostly concerned with Prolactin, Anterior pituitary, Radioimmunoassay, Neuropeptide and Interleukin.
His Somatostatin research is multidisciplinary, incorporating perspectives in Immunohistochemistry, Gastrin, Sensory system, Growth hormone secretion and Spinal cord.
His work in Hypothalamus addresses subjects such as Posterior pituitary, which are connected to disciplines such as Adrenal gland.
In his research on the topic of Luteinizing hormone, Central nervous system is strongly related with Endocrine system.
His most cited work include:
- Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells (1631 citations)
- Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence (1070 citations)
- Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). (815 citations)
What are the main themes of his work throughout his whole career to date?
Akira Arimura mostly deals with Internal medicine, Endocrinology, Hormone, Somatostatin and Hypothalamus.
Follicle-stimulating hormone, Pituitary adenylate cyclase-activating peptide, Median eminence, Receptor and Prolactin are the subjects of his Internal medicine studies.
His Endocrinology research is multidisciplinary, incorporating elements of Neuropeptide and Vasoactive intestinal peptide.
Akira Arimura works mostly in the field of Vasoactive intestinal peptide, limiting it down to topics relating to Cyclase and, in certain cases, Molecular biology.
His Hormone study combines topics in areas such as Basal, Stimulation and Pharmacology.
His Somatostatin study integrates concerns from other disciplines, such as Immunohistochemistry, Somatostatin secretion, Secretion, Antiserum and Growth hormone secretion.
He most often published in these fields:
- Internal medicine (89.57%)
- Endocrinology (87.77%)
- Hormone (28.96%)
What were the highlights of his more recent work (between 1995-2016)?
- Internal medicine (89.57%)
- Endocrinology (87.77%)
- Adenylate kinase (9.71%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Endocrinology, Adenylate kinase, Cyclase and Neuropeptide.
His study in Hormone, Anterior pituitary, Radioimmunoassay, Immunohistochemistry and Pituitary gland are all subfields of Internal medicine.
His study in Endocrinology is interdisciplinary in nature, drawing from both Receptor and Pituitary adenylate cyclase-activating peptide, Vasoactive intestinal peptide.
His Adenylate kinase research incorporates themes from Neuroprotection, Protein kinase A and Cell biology.
His study explores the link between Cyclase and topics such as Molecular biology that cross with problems in In situ hybridization and Olfactory bulb.
His study looks at the intersection of Neuropeptide and topics like Stria terminalis with Axon.
Between 1995 and 2016, his most popular works were:
- International Union of Pharmacology. XVIII. Nomenclature of Receptors for Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide (696 citations)
- Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. (463 citations)
- Distribution of urocortin-like immunoreactivity in the central nervous system of the rat (238 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Endocrinology
- Enzyme
Akira Arimura spends much of his time researching Internal medicine, Endocrinology, Neuropeptide, Pituitary adenylate cyclase-activating peptide and Receptor.
The study incorporates disciplines such as Signal transduction and Nucleus in addition to Internal medicine.
His Endocrinology study focuses on Central nervous system in particular.
The concepts of his Neuropeptide study are interwoven with issues in Peripheral, Interleukin 6, Septal nuclei and Adrenocorticotropic hormone.
His Pituitary adenylate cyclase-activating peptide study incorporates themes from Proinflammatory cytokine, Cancer research and Kidney.
Akira Arimura interconnects Molecular biology and In situ hybridization in the investigation of issues within Receptor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
